nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Corrigendum to “Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?” [Pharmacol. Ther. 127(2) (2010) 95–107]
|
Geisler, Tobias |
|
2010 |
128 |
2 |
p. 385- 1 p. |
artikel |
2 |
Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise
|
Bharali, Dhruba J. |
|
2010 |
128 |
2 |
p. 324-335 12 p. |
artikel |
3 |
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
|
Millan, Mark J. |
|
2010 |
128 |
2 |
p. 229-273 45 p. |
artikel |
4 |
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders
|
Chiu, Chi-Tso |
|
2010 |
128 |
2 |
p. 281-304 24 p. |
artikel |
5 |
New therapeutic opportunities in epilepsy: A genetic perspective
|
Reid, Christopher A. |
|
2010 |
128 |
2 |
p. 274-280 7 p. |
artikel |
6 |
Targeting tissue oxidative damage by means of cell signaling modulators: The antioxidant concept revisited
|
Leonarduzzi, Gabriella |
|
2010 |
128 |
2 |
p. 336-374 39 p. |
artikel |
7 |
The development of MDA-7/IL-24 as a cancer therapeutic
|
Dent, Paul |
|
2010 |
128 |
2 |
p. 375-384 10 p. |
artikel |
8 |
The therapeutic potential of G-protein coupled receptors in Huntington's disease
|
Dowie, Megan J. |
|
2010 |
128 |
2 |
p. 305-323 19 p. |
artikel |